Pentadecapeptide Arginate is a custom-compounded peptide formulation designed to mimic the effects of BPC-157, a 15-amino-acid sequence known for its regenerative and protective properties. This version is not identical to BPC-157 but is structurally similar, with enhanced stability and bioavailability due to the inclusion of arginine.

⚠️ Note: While Pentadecapeptide Arginate is not FDA-approved, it may be prescribed legally through licensed compounding pharmacies.

Tissue Regeneration – Promotes healing in muscles, tendons, ligaments, nerves, and skin by supporting new blood vessel formation (angiogenesis) and collagen synthesis.

Anti-Inflammatory Effects – Helps reduce inflammation in tissues, potentially supporting recovery from chronic injuries or inflammatory conditions.

Gut Healing – Protects the gastrointestinal lining and accelerates recovery from ulcers or intestinal damage (e.g., due to NSAIDs).

Pentadecapeptide Arginate is most commonly found in injectable, oral, or topical forms. Usage depends on the condition being treated.

Oral: For gut health and systemic benefits.

Injection: Often used near injury sites (subcutaneously or intramuscularly) for targeted healing.

Topical: Occasionally used for skin or wound applications.

Always consult a healthcare provider before use, especially if using peptides for therapeutic purposes.

Yes, it has shown promise for:

Tendon and ligament repair

Muscle recovery

Nerve regeneration

Healing surgical wounds or chronic soft-tissue injuries

Most evidence comes from animal studies and anecdotal reports—human clinical data is still limited.

Pentadecapeptide Arginate is generally well-tolerated, and reported side effects are rare and mild. However, as with any compounded peptide therapy, individual responses may vary.

Possible side effects may include:

Mild nausea – Most commonly with oral or sublingual forms

Headache or dizziness – Typically transient and self-limiting

Injection site reactions – Redness, swelling, or slight discomfort if injected

Mild fatigue – Occasionally reported in the first few days of use

💡 Because Pentadecapeptide Arginate is a compounded formulation, side effect profiles may vary slightly depending on the specific delivery method and individual patient sensitivity.

There are no known serious or long-term adverse effects reported in clinical use to date. That said, as it is not FDA-approved, it has not undergone large-scale safety trials, and monitoring by your prescribing provider is important.

Patients should report any unexpected symptoms or changes to their healthcare provider to ensure appropriate guidance and dosage adjustments if needed.